Phase I Study of Quizartinib Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia Irrespective of FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Status
CORTES, Jorge E, KANTARJIAN, Hagop, LEVIS, Mark, FORAN, James M, GHIRDALADZE, Darejan, ZODELAVA, Mamia, BORTHAKUR, Gautam, GAMMON, Guy, TRONE, Denise, ARMSTRONG, Robert C, JAMES, Joyce
Published in Journal of clinical oncology (10.10.2013)
Published in Journal of clinical oncology (10.10.2013)
Get full text
Journal Article
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
Palumbo, Antonio, Hajek, Roman, Delforge, Michel, Kropff, Martin, Petrucci, Maria Teresa, Catalano, John, Gisslinger, Heinz, Wiktor-Jędrzejczak, Wiesław, Zodelava, Mamia, Weisel, Katja, Cascavilla, Nicola, Iosava, Genadi, Cavo, Michele, Kloczko, Janusz, Bladé, Joan, Beksac, Meral, Spicka, Ivan, Plesner, Torben, Radke, Joergen, Langer, Christian, Yehuda, Dina Ben, Corso, Alessandro, Herbein, Lindsay, Yu, Zhinuan, Mei, Jay, Jacques, Christian, Dimopoulos, Meletios A
Published in The New England journal of medicine (10.05.2012)
Published in The New England journal of medicine (10.05.2012)
Get full text
Journal Article
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
PALUMBO, Antonio, HAJEK, Roman, CASCAVILLA, Nicola, LOSAVA, Genadi, CAVO, Michele, KLOCZKO, Janusz, BLADE, Joan, BEKSAC, Meral, SPICKA, Ivan, PLESNER, Torben, RADKE, Joergen, LANGER, Christian, DELFORGE, Michel, BEN YEHUDA, Dina, CORSO, Alessandro, HERBEIN, Lindsay, ZHINUAN YU, MEI, Jay, JACQUES, Christian, DIMOPOULOS, Meletios A, KROPFF, Martin, PETRUCCI, Maria Teresa, CATALANO, John, GISSLINGER, Heinz, WIKTOR-JEDRZEJCZAK, Wiesław, ZODELAVA, Mamia, WEISEL, Katja
Published in The New England journal of medicine (10.05.2012)
Published in The New England journal of medicine (10.05.2012)
Get full text
Journal Article
An Open Label, Phase 2 Study to Assess the Efficacy and Safety of Tenalisib (RP6530), a PI3K δ/γ and SIK3 Inhibitor, in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Grosicki, Sebastian, Iosava, Genadi, Zodelava, Mamia, Tzvetkov, Nikolay, Robak, Tadeusz, Radinoff, Atanas, Routhu, Kasi Viswanath, Barde, Prajak, Nair, Ajit Mohanchandran
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
A phase II study of MT-3724, a novel CD20-targeting engineered toxin body, to evaluate safety, pharmacodynamics, and efficacy in subjects with relapsed or refractory diffuse large B-cell lymphoma
Diaz Duque, Adolfo Enrique, Perekhrestenko, Tetiana, Musteata, Vasile, Zodelava, Mamia, Guthrie, Troy H., Strack, Thomas, Burnett, Christine, Wilson, Sarah, Waltzman, Roger J., Baetz, Tara D., Persky, Daniel O.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A Phase 2 Study of MT-3724 to Evaluate Safety, Pharmacodynamics and Efficacy of MT-3724 for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Persky, Daniel O., Musteata, Vasile, Zodelava, Mamia, Perekhrestenko, Tetiana, Diaz, Adolfo E, Guthrie, Troy H., Strack, Thomas, Burnett, Christine, Wilson, Sarah, Baetz, Tara
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Monotherapy Activity with the First CD20-Targeted Immunotoxin, MT-3724, in Subjects with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Hamlin, Paul A., Musteata, Vasile, Zodelava, Mamia, Park, Steven I, Burnett, Christine, Dabovic, Kristina, Williams, Eric T, Higgins, Jack P, Persky, Daniel O.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Pharmacokinetic and Safety of CT-P10, a Biosimilar Candidate to the Rituximab Reference Product, in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma (AFL)
Coiffier, Bertrand, Sancho, Juan-Manuel, Jurczak, Wojciech, Kim, Jin Seok, Nagarkar, Raj V, Zhavrid, Edvard, Hernandez Rivas, Jose Angel, Prokharau, Aliaksandr, Zodelava, Mamia, Osmanov, Dzhelil, Ogura, Michinori, Buske, Christian, Kwak, Larry, Lee, Sang Joon, Lee, Sung Young, Bae, Yun Ju, Kim, Won Seog
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Final Results of A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Quizartinib (AC220) Administered Daily to Patients with Relapsed or Refractory Acute Myeloid Leukemia Irrespective of FLT3-ITD Status
Cortes, Jorge E., Kantarjian, Hagop M., Foran, James M., Ghirdaladze, Darejan, Zodelava, Mamia, Borthakur, Gautam, Gammon, Guy, Trone, Denise, Armstrong, Robert C, James, Joyce, Levis, Mark J.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
AC220, a Potent, Selective, Second Generation FLT3 Receptor Tyrosine Kinase (RTK) Inhibitor, in a First-in-Human (FIH) Phase 1 AML Study
Cortes, Jorge, Foran, James, Ghirdaladze, Darejan, DeVetten, Marcel P, Zodelava, Mamia, Holman, Peter, Levis, Mark J, Kantarjian, Hagop M, Borthakur, Gautam, James, Joyce, Zarringkar, Patrick P, Gunawardane, Ruwanthi N, Armstrong, Robert C, Padre, Norman M, Wierenga, Wendell, Corringham, Robert, Trikha, Mohit
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
Phase 1 AML Study of AC220, a Potent and Selective Second Generation FLT3 Receptor Tyrosine Kinase Inhibitor
Cortes, Jorge E., Ghirdaladze, Darejan, Foran, James M., DeVetten, Marcel P., Zodelava, Mamia, Levis, Mark J., Padre, Norman M., Joyce, James, Zarrinkar, Patrick P., Corringham, Robert
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Forodesine (FodosineTM), a PNP Inhibitor Active in Relapsed or Refractory T-Cell Leukemia Patients (Phase II Study)
Furman, Richard R., Iosava, Genadi, Isola, Luis, Ravandi, Farhad, Zodelava, Mamia, Bennett, J. Claude, Kilpatrick, J. Michael, Bantia, Shanta
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article